| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Incannex Healthcare Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 01.10. | Stonegate, Inc.: Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26 | 887 | Newsfile | Dallas, Texas--(Newsfile Corp. - October 1, 2026) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). IXHL's FY26... ► Artikel lesen | |
| 25.09. | Incannex Healthcare Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 09.09. | Incannex begins Phase 2 dosing study for sleep apnea drug | 2 | Investing.com | ||
| 09.09. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.08. | Incannex Healthcare: Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X | 263 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| 25.08. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.08. | Incannex receives final A$5.1m R&D tax incentive refund | 2 | Investing.com | ||
| 11.08. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.07. | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | 339 | GlobeNewswire (Europe) | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| 23.07. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Incannex receives U.S. patent for sleep apnea drug IHL-42X | 2 | Investing.com | ||
| 25.06. | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | 693 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| 25.06. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.06. | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | 564 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare: Incannex Announces Initiation of Research Coverage by Alliance Global Partners | 411 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| 09.06. | Incannex Healthcare Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 14.05. | Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | 713 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for... ► Artikel lesen | |
| 17.03. | Incannex Healthcare: Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement | 557 | GlobeNewswire (Europe) | MELBOURNE, Australia and NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact... ► Artikel lesen | |
| 12.03. | Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 613 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IHXL), ("Incannex" or the "Company") a clinical-stage biopharmaceutical company leading the... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,870 | -3,88 % | ROUNDUP/Gute Nachfrage nach Radiopharmaka: Eckert & Ziegler verdient mehr | BERLIN (dpa-AFX) - Beim Strahlen- und Medizintechnikkonzern Eckert & Ziegler ist das Geschäft mit Radiopharmaka auch im dritten Quartal der wichtigste Treiber geblieben. Binnen der ersten neun Monate... ► Artikel lesen | |
| MCKESSON | 986,40 | -0,52 % | McKesson Corp. Profit Advances In Q2 | WASHINGTON (dpa-AFX) - McKesson Corp. (MCK) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $1.218 billion, or $10.47 per share. This... ► Artikel lesen | |
| SENSEONICS | 9,900 | +7,03 % | Beta Bionics, Inc.: Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration | ||
| PERSPECTIVE THERAPEUTICS | 0,870 | +11,26 % | Perspective Therapeutics Analysts Slash Their Forecasts After Q3 Results | ||
| SRX GLOBAL | 0,909 | +1,68 % | SRX Global Inc: SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform | NORTH PALM BEACH, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the "Company" or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value... ► Artikel lesen | |
| ITONIC | 1,970 | +0,51 % | iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026 | BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (Nasdaq: ITOC) (the "Company"), a healthcare company developing digital medical technologies, today announced that at the extraordinary... ► Artikel lesen | |
| FRESENIUS | 53,75 | -0,20 % | Fresenius gewinnt eine neue Wachstumsstory | Fresenius hat den schwierigen Teil seiner Neuaufstellung offenbar weitgehend hinter sich gelassen. Der Gesundheitskonzern steigert seine Profitabilität, reduziert die finanzielle Belastung und hebt... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 14,170 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,710 | -0,35 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,300 | -1,59 % | Siemens-Aktie: Wie viel Luft hat die Dividende nach dem Healthineers-Abschied? | Siemens als Dividendenwert? Mit knapp 2 Prozent Rendite wirkt der Konzern eher wie ein Wachstumswert im Anzug. Doch die Ausschüttung klettert Jahr für Jahr, und jetzt trennt sich Siemens auch noch von... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,84 | +0,01 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| HEARTFLOW | 47,040 | -0,06 % | Heartflow stock tumbles despite strong growth beating Q3 expectations | ||
| GENEDX | 47,335 | +0,10 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| BILLIONTOONE | 97,56 | 0,00 % | BillionToOne auf der Stifel Healthcare Conference 2026: Wachstumsdynamik gewinnt an Breite | ||
| ALIGNMENT HEALTHCARE | 7,625 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |